Novo Nordisk, Emcure to launch weight-loss drug under new brand in India

Novo Nordisk has partnered with Emcure Pharmaceuticals to bring Poviztra, their latest weight-loss medication, to the Indian market. This collaboration builds on Novo Nordisk's prior success with Wegovy and follows Eli Lilly's competition in this space. After the announcement, Emcure Pharma's stock experienced a notable uptick, signaling investor confidence.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/W6fIDRJ
via IFTTT